Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACH7 TECHNOLOGIES LIMITED Major Shareholding Notification 2015

Feb 24, 2015

65285_rns_2015-02-24_4a494143-261a-4cde-ad1e-49b56fd2846d.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

603 page 1/2 15 July 2001

Form 603

Corporations Act 2001

Section 671B

Notice of initial substantial shareholder

To: Company name/ Scheme 3D MEDICAL LIMITED ACN/ ARSN 007 817 192 1. Details of substantial holder (1) Name CAPITOL HEALTH LIMITED ACN/ ARSN (if applicable) 117 391 812 The holder became substantial on 06/02/2015

2. Details of voting power

The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in on the date the substantial shareholder because a substantial shareholder are as follows:

Class of securities(4) Number of securities Person’s votes(5) VotingPower(6)
ORDINARY FULLY PAID SHARES 21,341,462 21,341,462 5.7%

3. Details in relevant interests

The nature of the relevant interest of the substantial holder or an associate had in the following voting securities on the date the substantial holder became a substantial holder are as follows:

Holderof relevantinterest Nature of relevantinterest (7) Nature of relevantinterest (7) Class andnumberofsecurities Class andnumberofsecurities
CAPITOL HEALTH LIMITED DIRECTLY HELD 21,341,462 ORDINARY FULLY PAID SHARES
ils of present registered holders
sons registered as holders of the securities referred to in paragraph 3 above are as follows:
Holder of relevant interest Registered holder of securities Person entitled to be registered as
holder(8)
Class and number of
securities
CAPITOL HEALTH LIMITED CAPITOL HEALTH LIMITED CAPITOL HEALTH LIMITED 21,341,462 ORDINARY
FULLY PAID SHARES

4. Details of present registered holders

The persons registered as holders of the securities referred to in paragraph 3 above are as follows:

5. Consideration

The consideration paid for each relevant interest referred to in paragraph 3 above, and acquired in the four months prior to the day that the substantial holder became a substantial holder is as follows:

Holderof relevantinterest Date ofacquisition Consideration(9) Consideration(9) Class andnumberofsecurities
Cash Non-cash
CAPITOL HEALTH LIMITED 06/02/2015 NIL VENDOR SHARES ISSUED IN
CONSIDERATION FOR THE ACQUISITION
OF SHARES HELD IN 3D MEDICAL LTD
BY SAFETY MEDICAL PRODUCTS LTD
(SUBSEQUENTLY RENAMED AS 3D
MEDICAL LIMITED)
21,341,462 ORDINARY FULLY
PAID SHARES

603 page 1/2 15 July 2001

6. Associates

The reasons the persons named in paragraph 3 above are associates of the substantial shareholder are as follows:

==> picture [506 x 687] intentionally omitted <==

----- Start of picture text -----

Name and ACN/ARSN (if applicable) Nature of association
The addresses of persons named in this form are as follows:
Name Address
CAPITOL HEALTH LIMITED LEVEL 3, 81 LORIMER STREET
DOCKLANDS 3008
print name DOMINIK KUCERA capacity DIRECTOR
date 25 FEBRUARY 2015
sign here
DIRECTIONS
If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an
equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to
throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 7 of the
form.
See the definition of "associate" in section 9 of the Corporations Act 2001.
See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.
The voting shares of a company constitute one class unless divided into separate classes.
The total number of votes attached to all the voting shares in the company or voting interests in the scheme (if any) that the person or an associate has a relevant
interest in.
The person's votes divided by the total votes in the body corporate or scheme multiplied by 100.
Include details of:
(a) any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any document
setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must
accompany this form, together with a written statement certifying this contract, scheme or arrangement; and
(b) any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which
the relevant interest relates (indicating clearly the particular securities to which the qualification applies).
See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.
If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write "unknown".
Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become
entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be
included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom
the relevant interest was acquired.
----- End of picture text -----

6. Addresses

The addresses of persons named in this form are as follows:

Signature

  • (1) If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 7 of the form.

  • (2) See the definition of "associate" in section 9 of the Corporations Act 2001.

  • (3) See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.

  • (4) The voting shares of a company constitute one class unless divided into separate classes.

  • (5) The total number of votes attached to all the voting shares in the company or voting interests in the scheme (if any) that the person or an associate has a relevant interest in.

  • (6) The person's votes divided by the total votes in the body corporate or scheme multiplied by 100.

  • (7) Include details of:

  • (8) If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write "unknown".

  • (9) Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.